Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 23 | 2023 | 711 | 3.340 |
Why?
|
| Pouchitis | 7 | 2024 | 44 | 2.220 |
Why?
|
| Crohn Disease | 14 | 2023 | 730 | 1.920 |
Why?
|
| Proctocolectomy, Restorative | 5 | 2022 | 87 | 1.300 |
Why?
|
| Inflammatory Bowel Diseases | 9 | 2022 | 549 | 1.220 |
Why?
|
| Colonic Pouches | 5 | 2022 | 67 | 1.190 |
Why?
|
| Ustekinumab | 2 | 2020 | 47 | 0.850 |
Why?
|
| Capsule Endoscopes | 1 | 2017 | 5 | 0.620 |
Why?
|
| Ileal Neoplasms | 1 | 2017 | 9 | 0.610 |
Why?
|
| Dysbiosis | 2 | 2016 | 70 | 0.600 |
Why?
|
| Foreign Bodies | 1 | 2017 | 63 | 0.570 |
Why?
|
| Gastrointestinal Agents | 4 | 2020 | 161 | 0.490 |
Why?
|
| Intestinal Mucosa | 4 | 2019 | 797 | 0.460 |
Why?
|
| Microbiota | 3 | 2016 | 381 | 0.460 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 243 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2019 | 930 | 0.450 |
Why?
|
| Transcriptome | 1 | 2017 | 580 | 0.430 |
Why?
|
| Retrospective Studies | 21 | 2022 | 8489 | 0.430 |
Why?
|
| Colitis | 3 | 2021 | 239 | 0.420 |
Why?
|
| Intestines | 2 | 2016 | 411 | 0.420 |
Why?
|
| Remission Induction | 8 | 2023 | 722 | 0.400 |
Why?
|
| Autophagy | 1 | 2012 | 149 | 0.380 |
Why?
|
| Adipose Tissue | 1 | 2012 | 240 | 0.370 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1169 | 0.360 |
Why?
|
| Colon | 5 | 2021 | 496 | 0.350 |
Why?
|
| Treatment Outcome | 12 | 2023 | 7993 | 0.320 |
Why?
|
| Cyclosporine | 2 | 2019 | 234 | 0.320 |
Why?
|
| Humans | 39 | 2024 | 86643 | 0.310 |
Why?
|
| Inflammation | 6 | 2023 | 920 | 0.300 |
Why?
|
| Interleukin-10 | 3 | 2017 | 149 | 0.290 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 61 | 0.290 |
Why?
|
| Postoperative Complications | 5 | 2022 | 2207 | 0.290 |
Why?
|
| Ileum | 4 | 2021 | 159 | 0.280 |
Why?
|
| Bacteroides fragilis | 2 | 2023 | 42 | 0.270 |
Why?
|
| Immunosuppressive Agents | 3 | 2020 | 977 | 0.260 |
Why?
|
| Adult | 17 | 2023 | 25648 | 0.260 |
Why?
|
| Male | 20 | 2023 | 40965 | 0.250 |
Why?
|
| Indans | 1 | 2023 | 31 | 0.240 |
Why?
|
| Oxadiazoles | 1 | 2023 | 46 | 0.230 |
Why?
|
| Calcineurin Inhibitors | 2 | 2021 | 54 | 0.230 |
Why?
|
| Ulcer | 2 | 2022 | 36 | 0.230 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 191 | 0.220 |
Why?
|
| Infliximab | 2 | 2020 | 151 | 0.220 |
Why?
|
| Enterocolitis | 1 | 2022 | 12 | 0.220 |
Why?
|
| Recurrence | 6 | 2021 | 1139 | 0.210 |
Why?
|
| Opportunistic Infections | 1 | 2022 | 59 | 0.210 |
Why?
|
| Steroids | 2 | 2020 | 177 | 0.210 |
Why?
|
| Treatment Failure | 2 | 2019 | 285 | 0.210 |
Why?
|
| Prospective Studies | 6 | 2023 | 4213 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 144 | 0.200 |
Why?
|
| Piperidines | 2 | 2022 | 181 | 0.200 |
Why?
|
| Colonic Diseases | 1 | 2021 | 65 | 0.190 |
Why?
|
| Biosimilar Pharmaceuticals | 1 | 2020 | 20 | 0.190 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 19 | 0.190 |
Why?
|
| Surgical Stomas | 1 | 2020 | 22 | 0.180 |
Why?
|
| Female | 16 | 2023 | 44532 | 0.180 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 103 | 0.180 |
Why?
|
| Aspirin | 1 | 2021 | 156 | 0.180 |
Why?
|
| Maintenance Chemotherapy | 1 | 2019 | 76 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 143 | 0.170 |
Why?
|
| Drug Substitution | 1 | 2019 | 25 | 0.170 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 1801 | 0.170 |
Why?
|
| Ileal Diseases | 1 | 2019 | 25 | 0.170 |
Why?
|
| Drug Resistance | 1 | 2019 | 256 | 0.170 |
Why?
|
| Induction Chemotherapy | 1 | 2019 | 147 | 0.170 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2019 | 19 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 94 | 0.170 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 153 | 0.160 |
Why?
|
| Pyrroles | 1 | 2019 | 184 | 0.160 |
Why?
|
| Histocytochemistry | 1 | 2017 | 130 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.150 |
Why?
|
| Radiography, Abdominal | 1 | 2017 | 71 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 113 | 0.150 |
Why?
|
| Microscopy | 1 | 2017 | 87 | 0.150 |
Why?
|
| Bacteroides | 1 | 2016 | 33 | 0.140 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 25 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2019 | 370 | 0.140 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 139 | 0.140 |
Why?
|
| Administration, Rectal | 1 | 2015 | 12 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2018 | 125 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2019 | 971 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 88 | 0.130 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 184 | 0.130 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 190 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 231 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 295 | 0.120 |
Why?
|
| Disease Progression | 2 | 2019 | 1531 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 746 | 0.120 |
Why?
|
| Metagenome | 1 | 2014 | 102 | 0.120 |
Why?
|
| Immune System | 1 | 2014 | 93 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2015 | 326 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2022 | 2767 | 0.110 |
Why?
|
| Colonoscopy | 3 | 2019 | 264 | 0.110 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 21 | 0.110 |
Why?
|
| Beclin-1 | 1 | 2012 | 14 | 0.110 |
Why?
|
| Middle Aged | 10 | 2020 | 25028 | 0.110 |
Why?
|
| Endoscopy | 3 | 2021 | 332 | 0.110 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2023 | 39 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 199 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 176 | 0.100 |
Why?
|
| Genome | 1 | 2014 | 372 | 0.100 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 32 | 0.100 |
Why?
|
| Dialysis Solutions | 1 | 1990 | 7 | 0.100 |
Why?
|
| Lactates | 1 | 1990 | 37 | 0.100 |
Why?
|
| Butyrates | 1 | 2011 | 42 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 74 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 5976 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 3640 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2016 | 1351 | 0.090 |
Why?
|
| Anastomosis, Surgical | 2 | 2022 | 267 | 0.090 |
Why?
|
| Aged | 4 | 2020 | 18415 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2012 | 673 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 455 | 0.080 |
Why?
|
| Biopsy | 1 | 2012 | 1163 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2021 | 303 | 0.080 |
Why?
|
| Colectomy | 2 | 2020 | 167 | 0.080 |
Why?
|
| Risk Factors | 4 | 2020 | 5417 | 0.080 |
Why?
|
| Inpatients | 2 | 2021 | 297 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 916 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 1990 | 355 | 0.080 |
Why?
|
| Propensity Score | 2 | 2018 | 136 | 0.080 |
Why?
|
| Hemodynamics | 1 | 1990 | 710 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2022 | 927 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2601 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1981 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 556 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2011 | 534 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1196 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2271 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1197 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 683 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3092 | 0.070 |
Why?
|
| Phenotype | 2 | 2022 | 2378 | 0.060 |
Why?
|
| Amines | 1 | 2024 | 27 | 0.060 |
Why?
|
| Amides | 1 | 2024 | 60 | 0.060 |
Why?
|
| Bile | 1 | 2023 | 57 | 0.060 |
Why?
|
| Catalysis | 1 | 2024 | 203 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 83 | 0.060 |
Why?
|
| Amino Acids | 1 | 2024 | 252 | 0.060 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 76 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2023 | 170 | 0.050 |
Why?
|
| Osteonectin | 1 | 2022 | 22 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1924 | 0.050 |
Why?
|
| Ostomy | 1 | 2020 | 15 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 5210 | 0.040 |
Why?
|
| Vitamin D | 1 | 2021 | 261 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 41 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 244 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 16 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 46 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 68 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 120 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 70 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 826 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 69 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 684 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 115 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 91 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 168 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 860 | 0.040 |
Why?
|
| Medical Records | 1 | 2017 | 119 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2016 | 83 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2018 | 181 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2017 | 149 | 0.040 |
Why?
|
| Metagenomics | 1 | 2016 | 83 | 0.030 |
Why?
|
| Illinois | 1 | 2017 | 462 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 409 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1106 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 295 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 236 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 241 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 376 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1376 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 849 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 1379 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 319 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 2894 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1019 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 26582 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 339 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3679 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2818 | 0.030 |
Why?
|
| Mice | 2 | 2016 | 11352 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1621 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2261 | 0.020 |
Why?
|
| Child | 1 | 2022 | 6927 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1990 | 37 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1990 | 60 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2232 | 0.020 |
Why?
|
| Acetates | 1 | 1990 | 66 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1990 | 90 | 0.020 |
Why?
|
| Phosphorus | 1 | 1990 | 118 | 0.020 |
Why?
|
| Potassium | 1 | 1990 | 281 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1041 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3241 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8981 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1990 | 1823 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1990 | 509 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1990 | 1143 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1384 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1578 | 0.020 |
Why?
|